Insulin icodec may improve glycaemic control with low hypoglycaemia risk
This study evaluated the efficacy and hypoglycaemia outcomes of once-weekly insulin icodec compared to once-daily basal insulin in adults with type 2 diabetes.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study evaluated the efficacy and hypoglycaemia outcomes of once-weekly insulin icodec compared to once-daily basal insulin in adults with type 2 diabetes.
This study explored the effects of an intensive lifestyle intervention on a patient with type 2 diabetes and nephrectomy, resulting in significant health improvements.
This pilot study evaluated the effects of Interval Walking Training (IWT) on patients with Type 2 Diabetes, finding significant improvements in HDL-C and VO2 peak.
This study compared nonsurgical periodontal therapy with and without diode laser in type 2 diabetes patients with periodontitis, finding significant improvements in several periodontal outcomes.
This study evaluated the efficacy and safety of lobeglitazone as an add-on therapy for patients with type 2 diabetes inadequately controlled with metformin and empagliflozin, finding significant improvements in HbA1c levels.
This study compared the effects of a Low Glycemic Load Diet and a Conventional Energy-Restricted Diet on central obesity and lipid profiles in newly diagnosed type 2 diabetes patients.
This study examined the impact of magnesium deficiency on diabetes and its complications, finding significant reductions in serum calcium, urinary magnesium, cholesterol, and LDL cholesterol levels with simvastatin treatment.
This study evaluated the impact of adjunctive metformin therapy on glycemic control in overweight/obese youth with type 1 diabetes, finding no significant differences in key outcomes.
The study evaluated an mHealth-enabled hierarchical diabetes management intervention and found it improved glycemic control compared to usual care.
This study evaluated the effectiveness of the Rama Diabetes Care app for managing uncontrolled Type 2 diabetes in adults. While some improvements were noted, not all findings were statistically significant.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.